Healthcare ❯ Medical Devices ❯ Continuous Glucose Monitoring ❯ Regulatory Compliance

FDA Regulations

DexCom Investors Face Late-December Deadlines in Suits Over FDA-Flagged CGM Changes

Investor law firms set late-December deadlines tied to suits referencing an FDA warning over unauthorized CGM sensor changes.

DexCom Faces Wave of Securities Class Actions Over FDA-Faulted CGM Changes